← Back to Screener
Mannatech Inc. (MTEX)
Price$5.02
Favorite Metrics
Price vs S&P 500 (26W)-50.47%
Price vs S&P 500 (4W)-30.33%
Market Capitalization$9.90M
P/E Ratio (Annual)3.98x
Indicated Dividend Yield (Annual)8.83%
All Metrics
P/CF (Annual)4.38x
Book Value / Share (Quarterly)$3.66
P/TBV (Annual)3.01x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-9.65%
Cash Flow / Share (Quarterly)$-2.09
Price vs S&P 500 (YTD)-39.95%
Gross Margin (TTM)76.33%
Net Profit Margin (TTM)-1.50%
EPS (TTM)$-0.86
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-0.86
Revenue Growth (5Y)-5.66%
EPS (Annual)$1.32
Dividend / Share (Annual)$0.00
ROI (Annual)19.84%
Gross Margin (Annual)77.60%
Net Profit Margin (5Y Avg)1.48%
Cash / Share (Quarterly)$3.76
Revenue Growth QoQ (YoY)-8.08%
EPS Growth (5Y)-0.80%
P/E Normalized (Annual)3.98x
ROA (Last FY)6.91%
Revenue Growth TTM (YoY)-9.17%
EBITD / Share (TTM)$1.02
ROE (5Y Avg)8.05%
Operating Margin (TTM)0.54%
Cash Flow / Share (Annual)$1.04
P/B Ratio1.42x
P/B Ratio (Quarterly)2.72x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.06x
Net Interest Coverage (TTM)-5.81x
ROA (TTM)-4.75%
EV / EBITDA (TTM)3.31x
EPS Incl Extra (Annual)$1.32
Current Ratio (Annual)1.25x
Quick Ratio (Quarterly)0.48x
3-Month Avg Trading Volume0.02M
52-Week Price Return-59.73%
EV / Free Cash Flow (Annual)3.26x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$4.46
P/S Ratio (Annual)0.08x
Asset Turnover (Annual)3.27x
52-Week High$12.45
Operating Margin (5Y Avg)1.76%
EPS Excl Extra (Annual)$1.32
CapEx CAGR (5Y)-24.62%
Tangible BV CAGR (5Y)-20.86%
26-Week Price Return-41.72%
Quick Ratio (Annual)0.67x
13-Week Price Return-34.99%
Total Debt / Equity (Annual)0.46x
Current Ratio (Quarterly)1.13x
Enterprise Value$6.409
Revenue / Share Growth (5Y)-0.99%
Asset Turnover (TTM)3.17x
Book Value / Share Growth (5Y)-16.67%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.12x
Pretax Margin (Annual)3.17%
Cash / Share (Annual)$6.05
3-Month Return Std Dev85.31%
Gross Margin (5Y Avg)77.31%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-19.06%
EBITDA Interim CAGR (5Y)10.62%
ROE (Last FY)28.91%
Net Interest Coverage (Annual)0.22x
EPS Basic Excl Extra (Annual)$1.32
P/FCF (TTM)5.31x
Receivables Turnover (TTM)3680.37x
Total Debt / Equity (Quarterly)0.53x
EPS Incl Extra (TTM)$-0.86
Receivables Turnover (Annual)2143.02x
ROI (TTM)-14.98%
P/S Ratio (TTM)0.09x
Pretax Margin (5Y Avg)2.26%
Revenue / Share (Annual)$62.53
Tangible BV / Share (Annual)$4.46
Free OCF CAGR (5Y)-11.90%
Price vs S&P 500 (52W)-64.43%
Year-to-Date Return-36.96%
5-Day Price Return4.02%
EPS Normalized (Annual)$1.32
ROA (5Y Avg)3.68%
Net Profit Margin (Annual)2.11%
Month-to-Date Return-10.02%
Cash Flow / Share (TTM)$-2.94
EBITD / Share (Annual)$1.57
EPS Growth (3Y)-34.34%
Operating Margin (Annual)1.21%
LT Debt / Equity (Annual)0.34x
ROI (5Y Avg)6.69%
LT Debt / Equity (Quarterly)0.42x
EPS Basic Excl Extra (TTM)$-0.86
P/TBV (Quarterly)3.01x
P/B Ratio (Annual)2.94x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)2.26x
Pretax Margin (TTM)-0.20%
Book Value / Share (Annual)$4.57
Price vs S&P 500 (13W)-37.85%
Net Margin Growth (5Y)0.19%
Dividend Yield (TTM)0.00%
Beta0.75x
P/FCF (Annual)5.04x
Revenue / Share (TTM)$58.08
ROE (TTM)-22.75%
52-Week Low$4.67
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
MTEXMannatech Inc. | 0.09x | -9.17% | 76.33% | -0.80% | $5.02 |
CRONCronos Group Inc. Common Share | 6.99x | 24.63% | 42.81% | -49.98% | $2.76 |
TLRYTilray Brands, Inc. Common Stock | 0.97x | 3.82% | 27.68% | — | $7.15 |
CGCCanopy Growth Corporation Common Shares | 2.55x | 0.59% | 26.56% | — | $1.20 |
NAGENiagen Bioscience, Inc. Common Stock | 3.01x | 29.95% | 64.28% | — | $4.87 |
USNAUSANA Health Sciences Inc | 0.41x | 5.88% | 78.29% | -37.04% | $20.64 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.54 |
MDWDMediWound Ltd. | 13.35x | -16.14% | 19.19% | — | $17.35 |
ACBAurora Cannabis Inc. Common Shares | 0.77x | 16.54% | 1.35% | — | $3.72 |
BTMDBiote Corp. Class A Common Stock | 0.46x | -2.52% | 71.46% | -26.84% | $2.24 |
FTLFFitLife Brands, Inc. Common Stock | 1.29x | 1.34% | 37.58% | -20.04% | $8.99 |
About
Mannatech Inc is a wellness company that develops and sells nutritional supplements, skincare products, and weight-management solutions. The company operates across three major regions—the Americas, Europe/Middle East/Africa, and Asia/Pacific—with the Americas generating the majority of its revenue. Its product portfolio targets consumers seeking health and anti-aging benefits.